Drug intelligence / Profile preview

ethyl salicylate

Development stage
Unknown
Modality
Small Molecules
Administration
Topical
01

Overview

Ethyl salicylate is a small molecule analgesic and anti-inflammatory agent belonging to the salicylate class. It is the ethyl ester of salicylic acid and is primarily used topically for the relief of musculoskeletal pain and inflammation, including sports-related pain. Its mechanism of action involves inhibition of cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2) enzymes, leading to reduced prostaglandin synthesis and thus decreased pain and inflammation. Additionally, it acts as a counter-irritant by promoting local vasodilation when applied to the skin. Ethyl salicylate is also used in perfumery and artificial flavors due to its pleasant wintergreen-like odor.

Other names
ethyl 2-hydroxybenzoateethyl2-hydroxybenzoateethyl-2-hydroxybenzoateethyl o-hydroxybenzoatesalicylic acid ethyl estersalicylic ethersalicylic ethyl ester
02

Targets

RHOA (Ras homolog gene family member A)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on ethyl salicylate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ethyl salicylate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call